Shots: Sobi to sell its US FDA’s Priority Review Voucher to AstraZeneca for $95M in cash. The PRV was acquired as part of the acquisition of the emapalumab from Novimmune […]readmore
Tags : Buy
Shots: Catalent to purchase BMS’ oral solid, biologics, and sterile product manufacturing and packaging facility and will continue to manufacture BMS’s current product portfolio at the site, providing facilities in […]readmore